Ciro et al. reflect on how the legal regulation of drug markets in Colombia may act as reparations for past inequality and harm, and advance the interconnection of drug policy reform and reparative justice.
The Eastern and Central European and Central Asian Commission on Drug Policy calls to attention the external and internal elements affecting the drug situation in the region, and highlights opportunities for effective and humane drug policy reform.
C-EHRN explore the various challenges harm reduction workers encounter in their work and how those challenges affect them and their organisations, as well as coping mechanisms and organisational opportunities for support.
C-EHRN reports on the challenges faced and good practices by civil society organisations in Finland, Ireland, Greece and Hungary as they engage their governments in drug policy reform.
The Vienna and New York NGO Committees on Drugs release a report outlining the issues, challenges, and opportunities experienced by civil society working in the field of drugs.
Holland et. al. advocate for urgent implementation and rapid evidence generation for safer drug supply initiatives, especially in areas where drug deaths are escalating due to an unregulated drug supply.
Rammohan et. al. report decreased overdose mortality rates in areas with a supervised consumption services, underscoring the need and value of these interventions.
C-EHRN argues for coordinated, context-dependent, and well-funded responses, including harm reduction strategies, to achieve the 2030 elimination goal.
